These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27280542)

  • 41. Fetal fibronectin versus cervical length as predictors of preterm birth in twin pregnancy with or without 17-hydroxyprogesterone caproate.
    Combs CA; Garite TJ; Maurel K; Das A;
    Am J Perinatol; 2014 Dec; 31(12):1023-30. PubMed ID: 24566755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The predictive value of quantitative fibronectin testing in combination with cervical length measurement in symptomatic women.
    Bruijn MM; Kamphuis EI; Hoesli IM; Martinez de Tejada B; Loccufier AR; Kühnert M; Helmer H; Franz M; Porath MM; Oudijk MA; Jacquemyn Y; Schulzke SM; Vetter G; Hoste G; Vis JY; Kok M; Mol BW; van Baaren GJ
    Am J Obstet Gynecol; 2016 Dec; 215(6):793.e1-793.e8. PubMed ID: 27542720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Independent Association of a Short Cervix, Positive Fetal Fibronectin, Amniotic Fluid Sludge, and Cervical Funneling with Spontaneous Preterm Birth in Twin Pregnancies.
    Spiegelman J; Booker W; Gupta S; Lam-Rochlin J; Rebarber A; Saltzman DH; Monteagudo A; Fox NS
    Am J Perinatol; 2016 Oct; 33(12):1159-64. PubMed ID: 27434692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of Fetal Fibronectin and Phosphorylated Insulin-Like Growth Factor Binding Protein-1 Testing to Predict Preterm Delivery in Symptomatic Women: A 10-Year Retrospective Study.
    Chen MX; Dansereau J; Hoag GN
    J Obstet Gynaecol Can; 2020 Aug; 42(8):971-976. PubMed ID: 32345553
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of prevaginal and postvaginal manipulation fetal fibronectin.
    Turitz AL; Ackerman CM; Johnson DL; Bank TC; Duong JK; Lee SM; Gyamfi-Bannerman C
    Am J Obstet Gynecol; 2016 May; 214(5):646.e1-6. PubMed ID: 26924744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of additive effect of quantitative fetal fibronectin to cervical length for prediction of spontaneous preterm birth among asymptomatic high-risk women.
    Tran TL; Jwala S; Terenna C; McGregor A; Das A; Baxter JK; Berghella V
    J Matern Fetal Neonatal Med; 2020 Aug; 33(15):2628-2634. PubMed ID: 30612481
    [No Abstract]   [Full Text] [Related]  

  • 47. Risk factors for preterm delivery: do they add to fetal fibronectin testing and cervical length measurement in the prediction of preterm delivery in symptomatic women?
    van Baaren GJ; Bruijn MM; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers HC; Spaanderman ME; Bloemenkamp KW; Haak MC; Bolte AC; Bax CJ; Cornette JM; Duvekot JJ; Nij Bijvanck BW; van Eijck J; Franssen MT; Sollie KM; Vandenbussche FP; Woiski M; Bossuyt PM; Opmeer BC; Mol BW
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():79-85. PubMed ID: 26182836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis.
    Melchor JC; Khalil A; Wing D; Schleussner E; Surbek D
    Ultrasound Obstet Gynecol; 2018 Oct; 52(4):442-451. PubMed ID: 29920825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Preterm Prediction Study: prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
    Mercer BM; Goldenberg RL; Meis PJ; Moawad AH; Shellhaas C; Das A; Menard MK; Caritis SN; Thurnau GR; Dombrowski MP; Miodovnik M; Roberts JM; McNellis D
    Am J Obstet Gynecol; 2000 Sep; 183(3):738-45. PubMed ID: 10992202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the ability of cervical length and fetal fibronectin measurement to predict preterm delivery in asymptomatic women with risk factors.
    Zhou MX; Zhou J; Bao Y; Chen YQ; Cai C
    J Matern Fetal Neonatal Med; 2015 Jan; 28(2):153-7. PubMed ID: 24678648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Performance of cervicovaginal fetal fibronectin in a community hospital setting.
    Incerti M; Ghidini A; Korker V; Pezzullo JC
    Arch Gynecol Obstet; 2007 May; 275(5):347-51. PubMed ID: 17051404
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. NICHD Maternal Fetal Medicine Units Network.
    Goldenberg RL; Mercer BM; Meis PJ; Copper RL; Das A; McNellis D
    Obstet Gynecol; 1996 May; 87(5 Pt 1):643-8. PubMed ID: 8677060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling.
    Honest H; Forbes CA; Durée KH; Norman G; Duffy SB; Tsourapas A; Roberts TE; Barton PM; Jowett SM; Hyde CJ; Khan KS
    Health Technol Assess; 2009 Sep; 13(43):1-627. PubMed ID: 19796569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fetal fibronectin in cervicovaginal secretions as a predictor of preterm birth.
    Malak TM; Sizmur F; Bell SC; Taylor DJ
    Br J Obstet Gynaecol; 1996 Jul; 103(7):648-53. PubMed ID: 8688390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Significance of cervical gland area in predicting preterm birth for patients with threatened preterm delivery: comparison with cervical length and fetal fibronectin.
    Asakura H; Fukami T; Kurashina R; Tateyama N; Doi D; Takeshita T
    Gynecol Obstet Invest; 2009; 68(1):1-8. PubMed ID: 19321961
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fetal fibronectin in the cervicovaginal fluid of women with threatened preterm labour as a predictor of delivery before 34 weeks' gestation.
    Parker J; Bell R; Brennecke S
    Aust N Z J Obstet Gynaecol; 1995 Aug; 35(3):257-61. PubMed ID: 8546638
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of rapid bedside tests for phosphorylated insulin-like growth factor-binding protein 1 and fetal fibronectin to predict preterm birth.
    Tripathi R; Tyagi S; Mala YM; Singh N; Pandey NB; Yadav P
    Int J Gynaecol Obstet; 2016 Oct; 135(1):47-50. PubMed ID: 27388033
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
    Varley-Campbell J; Mújica-Mota R; Coelho H; Ocean N; Barnish M; Packman D; Dodman S; Cooper C; Snowsill T; Kay T; Liversedge N; Parr M; Knight L; Hyde C; Shennan A; Hoyle M
    Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined fetal fibronectin and cervical length and spontaneous preterm birth in asymptomatic triplet pregnancies.
    Fox NS; Rebarber A; Roman AS; Klauser CK; Peress D; Saltzman DH
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2308-11. PubMed ID: 22563765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cervicovaginal fetal fibronectin for the prediction of spontaneous preterm birth in multiple pregnancies: a systematic review and meta-analysis.
    Conde-Agudelo A; Romero R
    J Matern Fetal Neonatal Med; 2010 Dec; 23(12):1365-76. PubMed ID: 21067303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.